Published on 26/12/2025
Common Audit Findings in Centralized Monitoring: Causes and Prevention Strategies
Why Centralized Monitoring is a Focus in Inspections
As remote and hybrid trial models become the norm, centralized monitoring is no longer an experimental oversight technique—it is a regulatory expectation. ICH E6(R2) and the evolving ICH E6(R3) framework both support centralized methods as part of risk-based monitoring (RBM), but they also hold sponsors accountable for validating, documenting, and governing these methods appropriately. Regulators expect clear SOPs, role definitions, audit trails, and documentation in the Trial Master File (TMF) to support centralized oversight activities.
Agencies including the FDA, EMA, and MHRA have raised specific inspection findings related to centralized monitoring. These findings generally fall into five categories: lack of traceability, undocumented alerts or decisions, ineffective escalation of risk signals, inadequate CAPA, and failure to integrate centralized monitoring into broader quality systems. Sponsors must be prepared to explain not just what their dashboards show, but who reviewed the alerts, when, what action was taken, and whether the action was effective.
In this article, we explore real-world audit findings related to centralized monitoring, the underlying root causes, and how sponsors can proactively prevent these issues in future
Common Inspection Findings in Centralized Monitoring
Audit findings around centralized monitoring are increasingly detailed. Below are examples from recent inspections across global regulatory jurisdictions:
| Finding | Description | Likely Impact |
|---|---|---|
| Unreviewed Alerts | Dashboard alerts triggered but not formally reviewed or documented | Loss of data integrity oversight; possible GCP non-compliance |
| No Traceable Audit Trail | Missing records of who reviewed what alert and when | Failure to demonstrate oversight during inspection |
| Delayed CAPA | Signal escalated but no timely action or tracking | Patient safety risk; potential protocol deviations |
| Decisions Outside SOP | Escalation or closure actions taken without following defined workflow | SOP violation; training gaps; reproducibility issues |
| Insufficient TMF Documentation | Missing exports, screenshots, alert review notes in TMF | Non-compliance with ICH GCP documentation standards |
These issues often arise not from bad intent, but from gaps in role clarity, system configuration, or inadequate training. A well-documented centralized monitoring process requires more than dashboards—it requires procedural control, evidence management, and proactive audit preparation.
Root Causes of Centralized Monitoring Inspection Findings
To prevent recurrence of audit findings, sponsors must perform thorough root cause analysis. Based on recent GCP inspections, the most frequent root causes behind centralized monitoring deficiencies include:
- Absence of SOPs or monitoring plan sections describing centralized processes
- Alerts generated without pre-defined review timelines or reviewer assignments
- Failure to integrate dashboards into TMF workflows
- No audit trail functionality in the monitoring platform
- Incorrect assumptions that IT dashboards are “informational only”
- Over-reliance on CRAs for escalations without formal documentation path
In one inspection, the regulator asked for evidence of review for 17 alerts over a three-month period. The sponsor could provide dashboard screenshots but had no logs showing reviewer comments or decisions. As a result, the inspection report noted a failure in documented risk oversight and CAPA was requested within 30 days.
How to Prepare Centralized Monitoring Systems for Inspection
Inspection readiness for centralized monitoring starts with system validation and ends with TMF completeness. Best practices include:
- Validate the centralized monitoring platform as “fit for intended use” under GxP
- Ensure audit trail captures who reviewed each alert and when
- Establish SOPs for alert handling, documentation, and escalation
- Assign alert reviewers with defined roles and SLAs (e.g., 2 business days for initial review)
- Export and file alert logs, screenshots, and review notes to TMF monthly
- Include centralized monitoring metrics in sponsor quality dashboards
- Train all relevant staff on how to document decisions and actions properly
Regulators may use TMF samples to verify if the monitoring plan was followed, how alerts were processed, and whether resulting CAPA was effective. Thus, centralized monitoring processes must connect to broader oversight workflows including issue management, deviation logs, and risk governance documentation.
Case Study: Successful Audit Outcome with Robust Central Monitoring Traceability
In a multinational vaccine trial, centralized monitoring flagged Site 016 for high data entry lag and missing primary endpoints. The central monitor reviewed alerts within 48 hours and documented actions in an integrated tracker. The CRA conducted a virtual site visit and implemented a corrective workflow. All evidence, including dashboard export, review comments, follow-up emails, and CAPA plan, were filed in the TMF.
During the MHRA inspection, auditors requested centralized monitoring evidence. The sponsor provided a single indexed PDF with all alert documentation, reviewer signatures, timelines, and CAPA closure. The inspection closed with no findings on monitoring processes. Inspectors specifically praised the documentation structure and role-based review accountability.
CAPA Best Practices for Centralized Monitoring Deficiencies
If an audit finding does occur, sponsors should respond with structured CAPA that addresses not just symptoms but systemic process gaps. Elements of effective CAPA include:
- Clearly stated problem (e.g., alerts reviewed but not documented)
- Root cause (e.g., lack of SOP and unclear ownership)
- Corrective actions (e.g., SOP update, review form implementation)
- Preventive actions (e.g., training, quarterly TMF completeness checks)
- Effectiveness verification (e.g., sample check of 10 alert logs post-CAPA)
CAPA should be tracked in the sponsor’s Quality Management System (QMS), linked to the study-specific TMF, and followed through with documented closure. Sponsors may also want to audit their own centralized monitoring processes annually as part of their internal QA program.
Conclusion: Building Inspection-Ready Centralized Monitoring Systems
Centralized monitoring offers powerful capabilities for clinical oversight, but only if executed and documented correctly. With regulators focusing on remote oversight models, sponsors must ensure that monitoring dashboards, SOPs, reviewer logs, and TMF documentation are all aligned and inspection-ready.
Key takeaways for avoiding audit findings:
- Define clear roles and timelines for alert review
- Validate dashboards as GxP systems and maintain audit trails
- Document all decisions and actions with timestamps and reviewer names
- Integrate centralized monitoring into TMF and CAPA workflows
- Train monitoring staff and verify documentation regularly
By embedding these principles, sponsors can prevent regulatory observations, protect data integrity, and maintain high-quality oversight in remote and hybrid trials.